Case of progressive dysplasia concomitant with intralesional cidofovir administration for recurrent respiratory papillomatosis

Annals of Otology, Rhinology and Laryngology

Volumn 114, Issue 11, 2005, Pages 836-839

  Wemer, Richard D ^a   Lee, John H ^a   Hoffman, Henry T ^a,b   Robinson, Robert A ^a   Smith, Richard J H ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Antiviral; Carcinogen; Cidofovir; Recurrent respiratory papillomatosis

Indexed keywords

CIDOFOVIR; PARAFFIN; PYRIMIDINE NUCLEOTIDE;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CASE REPORT; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG APPROVAL; DYSPLASIA; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; HUMAN TISSUE; LARYNX; LOW LEVEL LASER THERAPY; PAPILLOMATOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RECURRENT RESPIRATORY PAPILLOMATOSIS; RETINITIS; TREATMENT INDICATION; VAPORIZATION;

EID: 32544460438     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940511401105     Document Type: Article

References (18)

1. Steinberg BM, Gallagher T, Stoler M, Abramson AL. Persistence and expression of human papillomavirus during interferon therapy. Arch Otolaryngol Head Neck Surg 1998;114:27-32.
2. Derkay CS. Task force on recurrent respiratory papillomas. A preliminary report. Arch Otolaryngol Head Neck Surg 1995;121:1386-91.
3. Yoder MG, Batsakis JG. Squamous cell carcinoma in solitary laryngeal papilloma. Otolaryngol Head Neck Surg 1980;88:745-8.
4. Van Cutsem E, Snoeck R, Van Ranst M, et al. Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine. J Med Virol 1995;45:230-5.
5. Snoeck R, Wellens W, Desloovere C, et al. Treatment of severe laryngeal papillomatosis with intralesional injections of cidofovir [(S)-1-(3-hydroxy-2- phosphonylmethoxypropyl)cytosine]. J Med Virol 1998;54:219-25.
6. Pransky SM, Magit AE, Kearns DB, Kang DR, Duncan NO. Intralesional cidofovir for recurrent respiratory papillomatosis in children. Arch Otolaryngol Head Neck Surg 1999;125:1143-8.
7. Pransky SM, Brewster DF, Magit AE, Kearns DB. Clinical update on 10 children treated with intralesional cidofovir injections for severe recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 2000;126:1239-43.
8. Chhetri DK, Blumin JH, Shapiro NL, Berke GS. Office-based treatment of laryngeal papillomatosis with percutaneous injection of cidofovir. Otolaryngol Head Neck Surg 2002;126:642-8.
9. Pransky SM, Albright JT, Magit AE. Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir. Laryngoscope 2003;113:1583-7.
10. El Hakim H, Waddell AN, Crysdale WS. Observations on the early results of treatment of recurrent respiratory papillomatosis using cidofovir. J Otolaryngol 2002;31:333-5.
11. Milczuk HA. Intralesional cidofovir for the treatment of severe juvenile recurrent respiratory papillomatosis: long-term results in 4 children. Otolaryngol Head Neck Surg 2003;128:788-94.
12. Lalezari JP, Stagg RJ, Kuppermann BD, et al. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med 1997;126:257-63.
13. Cidofovir. 2000 PDR Electronic Library. Montvale, NJ: Thomson Medical Economics, 2000.
14. Quick CA, Foucar E, Dehner LP. Frequency and significance of epithelial atypia in laryngeal papillomatosis. Laryngoscope 1979;89:550-60.
15. Gaylis B, Hayden RE. Recurrent respiratory papillomatosis: progression to invasion and malignancy. Am J Otolaryngol 1991;12:104-12.
16. Crissman JD, Sakr WA. Squamous intraepithelial neoplasia of the upper aerodigestive tract. In: Gnepp R, ed. Diagnostic surgical pathology of the head and neck. Philadelphia, Pa: WB Saunders, 2001:1-17.
17. Johnson JA, Gangemi JD. Selective inhibition of human papillomavirus-induced cell proliferation by (S)-1-[3-hydroxy-2- (phosphonylmethoxy)propyl]cytosine. Antimicrob Agents Chemother 1999;43:1198-205.
18. Wutzler P, Thust R. Genetic risks of antiviral nucleoside analogues - a survey. Antiviral Res 2001;49:55-74.